German CNS-focused specialist Neuraxpharm Group announced the launches in Europe of Tuzulby (methylphenidate hydrochloride) prolonged-release chewable tablets and Paxneury (guanfacine) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback